MedTrace Logo

A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer

NCT06168812 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2026-01-15

No results posted yet for this study

Summary

The purpose of this study is to find out how effective and safe glipizide is for lowering blood sugar in people with pancreatic cancer.

Conditions

Interventions

DRUG

Glipizide

The therapeutic intervention in this study involves the sulfonylurea glipizide in ER formulation.

Sponsors & Collaborators

Principal Investigators

  • James Flory, MD · Memorial Sloan Kettering Cancer Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-05
Primary Completion
2026-12-05
Completion
2026-12-05

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06168812 on ClinicalTrials.gov